CD86 and type 1 diabetes mellitus: Unconditioned BM-DC, exogenously administered into an inflammatory environment such as that in T1DM, can rapidly differentiate into potent immunostimulatory cells characterized by high-level surface expression of CD40, CD80, and CD86 (87, 88).